Advanced Biomed is trading 6.1% down at $5.75 on October 9, 2026, with no fresh company-specific announcement identified to explain the decline.
- The latest reported company item was a September 28 notice that it would be unable to file its annual 10-K by the deadline; this is background, not an established cause.
- The biotech sector is up 2.50%, and major U.S. indexes are also higher, unlike the stock.